Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J R Foster

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|November 19, 2017
Population in vitro-in vivo pharmacokinetic model of first-pass metabolism: itraconazole and hydroxy-itraconazoleAhmad Y Abuhelwa, Stuart Mudge, Richard N Upton, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 18, 2018
Mechanistic Assessment of the Effect of Omeprazole on the In Vivo Pharmacokinetics of Itraconazole in Healthy VolunteersAhmad Y Abuhelwa, Stuart Mudge, Richard N Upton, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 4, 2016
Food, gastrointestinal pH, and models of oral drug absorptionAhmad Y Abuhelwa, Desmond B Williams, Richard N Upton, et al.
Plos One|June 3, 2017
Pharmacokinetics of caspofungin acetate to guide optimal dosing in catsJana Leshinsky, Andrew McLachlan, David J R Foster, et al.
Current Topics in Medicinal Chemistry|December 21, 2018
Molecular Modeling Approaches for the Prediction of Selected Pharmacokinetic PropertiesEmilio S Petito, David J R Foster, Michael B Ward, et al.
Pharmaceutical Research|April 28, 2016
Population In Vitro-In Vivo Correlation Model Linking Gastrointestinal Transit Time, pH, and Pharmacokinetics: Itraconazole as a Model DrugAhmad Y Abuhelwa, Stuart Mudge, David Hayes, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 15, 2005
The acute disposition of (R)- and (s)-methadone in brain and lung of sheepDavid J R Foster, Richard N Upton, Andrew A Somogyi, et al.
Antimicrobial Agents and Chemotherapy|July 8, 2015
Population pharmacokinetic modeling of itraconazole and hydroxyitraconazole for oral SUBA-itraconazole and sporanox capsule formulations in healthy subjects in fed and fasted statesAhmad Y Abuhelwa, David J R Foster, Stuart Mudge, et al.
British Journal of Clinical Pharmacology|January 27, 2016
A model-based evaluation of single metrics for discriminating changes in rheumatoid arthritis disease activityJessica Wojciechowski, Michael D Wiese, Susanna M Proudman, et al.
British Journal of Clinical Pharmacology|November 14, 2014
A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquineJessica Wojciechowski, Michael D Wiese, Susanna M Proudman, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Journal of Pharmacokinetics and Pharmacodynamics|November 19, 2017
Population in vitro-in vivo pharmacokinetic model of first-pass metabolism: itraconazole and hydroxy-itraconazoleAhmad Y Abuhelwa, Stuart Mudge, Richard N Upton, et al.
European Journal of Drug Metabolism and Pharmacokinetics|October 18, 2018
Mechanistic Assessment of the Effect of Omeprazole on the In Vivo Pharmacokinetics of Itraconazole in Healthy VolunteersAhmad Y Abuhelwa, Stuart Mudge, Richard N Upton, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|December 4, 2016
Food, gastrointestinal pH, and models of oral drug absorptionAhmad Y Abuhelwa, Desmond B Williams, Richard N Upton, et al.
Plos One|June 3, 2017
Pharmacokinetics of caspofungin acetate to guide optimal dosing in catsJana Leshinsky, Andrew McLachlan, David J R Foster, et al.
Current Topics in Medicinal Chemistry|December 21, 2018
Molecular Modeling Approaches for the Prediction of Selected Pharmacokinetic PropertiesEmilio S Petito, David J R Foster, Michael B Ward, et al.
Pharmaceutical Research|April 28, 2016
Population In Vitro-In Vivo Correlation Model Linking Gastrointestinal Transit Time, pH, and Pharmacokinetics: Itraconazole as a Model DrugAhmad Y Abuhelwa, Stuart Mudge, David Hayes, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 15, 2005
The acute disposition of (R)- and (s)-methadone in brain and lung of sheepDavid J R Foster, Richard N Upton, Andrew A Somogyi, et al.
Antimicrobial Agents and Chemotherapy|July 8, 2015
Population pharmacokinetic modeling of itraconazole and hydroxyitraconazole for oral SUBA-itraconazole and sporanox capsule formulations in healthy subjects in fed and fasted statesAhmad Y Abuhelwa, David J R Foster, Stuart Mudge, et al.
British Journal of Clinical Pharmacology|January 27, 2016
A model-based evaluation of single metrics for discriminating changes in rheumatoid arthritis disease activityJessica Wojciechowski, Michael D Wiese, Susanna M Proudman, et al.
British Journal of Clinical Pharmacology|November 14, 2014
A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquineJessica Wojciechowski, Michael D Wiese, Susanna M Proudman, et al.
Pageof 6